InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Haviland Kate, Chief Operating Officer. Director active across 1 company, notably Blueprint Medicines Corp. Aggregated, 18 filings have been published. Split: 1 buy · 7 sells. Total volume traded: €3m. History available since 28 June 2021. The latest transaction was filed on 1 April 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations18 total
600 shares@ US$85.471.5% of flowCommon StockSEC:0001415889-25-009959:0
16,151 shares@ US$88.8041.8% of flowCommon StockSEC:0001415889-25-007384:0
35,200 shares0Common StockSEC:0001415889-25-006606:0
1,446 shares@ US$110.244.7% of flowCommon StockSEC:0001415889-25-001993:0
400 shares@ US$95.401.1% of flowCommon StockSEC:0001415889-24-028171:0
12,464 shares@ US$90.6932.1% of flowCommon StockSEC:0001415889-24-007560:0
40,000 shares0Common StockSEC:0001415889-24-007011:0
6,428 shares@ US$45.728.6% of flowCommon StockSEC:0001415889-23-004555:0
40,000 shares0Common StockSEC:0001415889-23-004261:0
1,100 shares@ US$43.981.5% of flowCommon StockSEC:0001415889-22-011111:0
Ideal exit: 31 Jul 2023 (T+270)
1,719 shares@ US$60.2733.5% of flowCommon StockSEC:0001415889-22-002733:0
40,000 shares0Common StockSEC:0001415889-22-002440:0
1,000 shares@ US$36.051.0% of flowCommon StockSEC:0001179110-21-010988
1,000 shares@ US$36.0511.4% of flowCommon StockSEC:0001179110-21-010988:0
1,000 shares@ US$36.0511.0% of flowCommon StockSEC:0001179110-21-008782:0
1,000 shares@ US$36.050.9% of flowCommon StockSEC:0001179110-21-008782
1,000 shares@ US$36.050.9% of flowCommon StockSEC:0001179110-21-007172
1,000 shares@ US$36.0510.9% of flowCommon StockSEC:0001179110-21-007172:0
18 of 18 declarations
About Haviland Kate
Kate Haviland is the Chief Operating Officer at Blueprint Medicines Corp. She is responsible for managing operations and implementing the company's strategy. Her expertise is crucial in ensuring growth and operational efficiency within Blueprint Medicines.
